
Lorenz
241 posts

Lorenz
@studerl
Stem cell biologist @MSKCancerCenter studying human PSCs for modeling development & disease and for cell therapy. Opinions are my own and do not represent MSK.


Had an awesome time hosting @FaranakFattahi for our motility visiting professorship. Phenomenal work on hPSC based models to interrogate ENS function and possible therapies. Very inspiring. Great company too! @MayoClinicGIHep @ANMSociety @esnm_eu @RomeFoundation @UCSF







🥇 The top spot goes to Drs. Stefan Irion (@bigosi) and Viviane Tabar (@TabarViviane)! This episode was recorded live at @BlueRockTx and focuses on bemdaneprocel — a stem cell-derived investigational cell therapy for Parkinson’s disease! #InternationalPodcastDay bit.ly/3N2wMhV



We have a postdoc opportunity to work on cell therapy for #Parkinson’s disease in a highly collaborative environment @MSKCancerCenter @MSKEducation Apply at mskcc.org/research-areas…

1) Just out @Nature today! We show that human TMEFF1 is a restriction factor for #Herpes simplex virus 1(HSV1) in the brain, by limiting NECTIN1—HSV1-gD mediated HSV1 entry into cortical neurons. TMEFF1 defect can underlie HSV1 #encephalitis. nature.com/articles/s4158…

(1) We are happy to share our new study, “SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency” @JExpMed! doi.org/10.1084/jem.20…. Accumulation of RNA lariats results in impaired antiviral immunity in hPSC-derived hindbrain neurons, underlying encephalitis. pic.twitter.com/UI6M7bwnxt



How to trigger age-related features in hPSC neurons? In a CRISPR screen @NatSaurat identified neddylation inhibition as a tool to trigger hallmarks of aging in neurons and selective degeneration in AD or PD but not isogenic control neurons. @cellstemcell bit.ly/3XBxCsA



Excited to share that my doctoral thesis work is out in @CellCellPress We investigated a molecular driver to trigger hPSC-derived midbrain dopamine neurons during engraftment in mice.



